Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial - Lau, DCW; Erichsen, L; Francisco, AM (Lancet, 2021)
et al.